the full WP markdown article
Eli Lilly Crushes Q4 2025 Earnings With Massive Zepbound Boost
Eli Lilly just dropped their Q4 2025 earnings, and the numbers are staggering – revenue way above expectations thanks to Zepbound and Mounjaro. But what does the strong 2026 guidance really mean for investors, and is the GLP-1 boom here to stay? ...
Financial market analysis from 04/02/2026. Market conditions may have changed since publication.
❝
Good investing is really just common sense. But it's not necessarily easy, because buying when others are desperately selling takes courage that is in rare supply in the investment world.
— John Bogle
Author
Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.
Previous
AMD Stock Drops 9% Post-Earnings: What Really Happened
Next
Sheryl Sandberg Backs AI Workplace Startup Slashwork
Related Articles
Global Markets
German Taxpayers Hit HardDrafting the migration cost article By Massive Migration Costs In 2025
German taxpayers are shouldering an enormous financial load from mass migration this year, with official figures pointing to tens of billions in costs. Yet the full picture reveals even deeper pressures on local budgets, services, and daily life. What does this mean for the future?
Jun 11, 2026
10 min read
Market News
Paramount Ups Bid to $31/Share in WBD Takeover Battle
Paramount just raised its all-cash bid for Warner Bros Discovery to $31 per share, complete with massive protections—could this finally topple the Netflix agreement? The board is weighing it now, but what happens if Netflix fights back...
Feb 26, 2026
6 min read
Bitcoin & Ethereum
Why Bitcoin Fell After PCE Inflation Data Shocked Markets
Bitcoin’s price tanked below $110K after PCE inflation hit 2.7%. Are institutions bailing out? What’s next for crypto? Dive into the full story to find out!
Sep 26, 2025
6 min read